{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:55:33Z","timestamp":1790805333042,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T00:00:00Z","timestamp":1545868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"European Union\u2019s H2020","doi-asserted-by":"publisher","award":["755225"],"award-info":[{"award-number":["755225"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Genethon"},{"DOI":"10.13039\/100007393","name":"Association Fran\u00e7aise contre les Myopathies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIAMI Association of Crigler-Najjar patients Italy"},{"DOI":"10.13039\/501100007151","name":"Conseil D\u00e9partemental de l'Essonne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007151","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ZonMW TGO"},{"name":"Najjar Fund"},{"name":"Beneficentia Stiftung"},{"name":"EU Marie Slodowska-Curie","award":["658712-3"],"award-info":[{"award-number":["658712-3"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.omtm.2018.12.011","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T11:43:57Z","timestamp":1546256637000},"page":"157-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome"],"prefix":"10.1016","volume":"12","author":[{"given":"Fanny","family":"Collaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Bortolussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Guianvarc\u2019h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sem J.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Bordet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Veron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Simon","family":"Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Rundwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine G.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lacoste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Luc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia v.","family":"Wittenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Le Bec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piter J.","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres F.","family":"Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ronzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Hebben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Mingozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2018.12.011_bib1","first-page":"169","article-title":"Congenital familial nonhemolytic jaundice with kernicterus","volume":"10","author":"Crigler","year":"1952","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtm.2018.12.011_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0002-9343(69)90224-1","article-title":"Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity","volume":"47","author":"Arias","year":"1969","journal-title":"Am. J. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib3","first-page":"545","article-title":"Liver transplantation in Crigler-Najjar syndrome type I disease","volume":"11","author":"Tu","year":"2012","journal-title":"HBPD INT"},{"key":"10.1016\/j.omtm.2018.12.011_bib4","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.3748\/wjg.14.3464","article-title":"Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives","volume":"14","author":"Lysy","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtm.2018.12.011_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1203\/PDR.0b013e3181598cc5","article-title":"Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial","volume":"62","author":"Hafkamp","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.omtm.2018.12.011_bib6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","article-title":"Current therapy for Crigler-Najjar syndrome type 1: report of a world registry","volume":"24","author":"van der Veere","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2018.12.011_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhep.2013.04.004","article-title":"Monogenic diseases that can be cured by liver transplantation","volume":"59","author":"Fagiuoli","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2018.12.011_bib8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/MPG.0000000000000703","article-title":"Adeno-associated virus vector-based gene therapy for monogenetic metabolic diseases of the liver","volume":"60","author":"Junge","year":"2015","journal-title":"J.\u00a0Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.omtm.2018.12.011_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/21678707.2018.1495558","article-title":"Advances in understanding disease mechanisms and potential treatments for Crigler\u2013Najjar syndrome","volume":"6","author":"Bortolussi","year":"2018","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omtm.2018.12.011_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2988","article-title":"Therapeutic in\u00a0vivo gene transfer for genetic disease using AAV: progress and challenges","volume":"12","author":"Mingozzi","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtm.2018.12.011_bib11","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1056\/NEJMoa1108046","article-title":"Adenovirus-associated virus vector-mediated gene transfer in hemophilia B","volume":"365","author":"Nathwani","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib12","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa1407309","article-title":"Long-term safety and efficacy of factor IX gene therapy in hemophilia B","volume":"371","author":"Nathwani","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib13","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa1708538","article-title":"Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant","volume":"377","author":"George","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib14","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-Factor VIII Gene Transfer in Severe Hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1182\/blood-2017-09-804419","article-title":"Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B","volume":"131","author":"Miesbach","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.12.011_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1096\/fj.11-195461","article-title":"Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer","volume":"26","author":"Bortolussi","year":"2012","journal-title":"FASEB\u00a0J."},{"key":"10.1016\/j.omtm.2018.12.011_bib17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1089\/hum.2013.233","article-title":"Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome","volume":"25","author":"Bortolussi","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ymthe.2006.01.014","article-title":"Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats","volume":"13","author":"Seppen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib19","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1038\/mtm.2016.49","article-title":"A translationally optimized AAV-UGT1A1 vector drives safe and long-lasting correction of Crigler-Najjar syndrome","volume":"3","author":"Ronzitti","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2018.12.011_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/gt.2017.75","article-title":"Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I","volume":"24","author":"Bo\u010dkor","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib21","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015","volume":"3","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.omtm.2018.12.011_bib22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2174\/156652310793797685","article-title":"Production, purification and characterization of adeno-associated vectors","volume":"10","author":"Ayuso","year":"2010","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib23","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.12.011_bib24","first-page":"230","article-title":"Hereditary Acholuric Jaundice in the Rat","volume":"50","author":"Gunn","year":"1944","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.omtm.2018.12.011_bib25","first-page":"369","article-title":"Animal model of human disease. Crigler-Najjar Syndrome. Animal model: hereditary nonhemolytic unconjugated hyperbilirubinemia in Gunn rats","volume":"69","author":"Cornelius","year":"1972","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omtm.2018.12.011_bib26","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0006-291X(91)90661-P","article-title":"Genetic defect of bilirubin UDP-glucuronosyltransferase in the hyperbilirubinemic Gunn rat","volume":"177","author":"Sato","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2018.12.011_bib27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.12.011_bib28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jhep.2016.05.012","article-title":"Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria","volume":"65","author":"D\u2019Avola","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2018.12.011_bib31","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1182\/blood-2010-10-314518","article-title":"The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver","volume":"117","author":"Martino","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.12.011_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jviromet.2013.10.038","article-title":"Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery","volume":"196","author":"Chahal","year":"2014","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.omtm.2018.12.011_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/mt.2013.268","article-title":"AAV empty capsids: for better or for worse?","volume":"22","author":"Wright","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib34","doi-asserted-by":"crossref","first-page":"194ra92","DOI":"10.1126\/scitranslmed.3005795","article-title":"Overcoming preexisting humoral immunity to AAV using capsid decoys","volume":"5","author":"Mingozzi","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.omtm.2017.12.004","article-title":"Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes","volume":"9","author":"Nass","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2018.12.011_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2015.048","article-title":"Analytical Ultracentrifugation as an Approach to Characterize Recombinant Adeno-Associated Viral Vectors","volume":"26","author":"Burnham","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2018.12.011_bib37","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/mt.2009.56","article-title":"Host and vector-dependent effects on the risk of germline transmission of AAV vectors","volume":"17","author":"Favaro","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1089\/hum.2009.031","article-title":"Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both genders","volume":"20","author":"Pa\u00f1eda","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib39","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ymthe.2004.12.022","article-title":"Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models","volume":"11","author":"Davidoff","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib40","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2018.12.011_bib41","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2007-03-080093","article-title":"Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver","volume":"110","author":"Mingozzi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2018.12.011_bib42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1089\/hum.2010.222","article-title":"Mycophenolate mofetil impairs transduction of single-stranded adeno-associated viral vectors","volume":"22","author":"Montenegro-Miranda","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib43","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1089\/hum.1997.8.16-1891","article-title":"Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice","volume":"8","author":"Snyder","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2018.12.011_bib44","first-page":"435","article-title":"Construction of adenovirus expression vectors by site-directed in\u00a0vivo recombination","volume":"1","author":"Thummel","year":"1982","journal-title":"J.\u00a0Mol. Appl. Genet."},{"key":"10.1016\/j.omtm.2018.12.011_bib45","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1182\/bloodadvances.2017010181","article-title":"Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors","volume":"1","author":"Meliani","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2018.12.011_bib46","doi-asserted-by":"crossref","first-page":"e82597","DOI":"10.1371\/journal.pone.0082597","article-title":"Adeno-associated viral vector serotype 5 poorly transduces liver in rat models","volume":"8","author":"Montenegro-Miranda","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050118301359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050118301359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:25Z","timestamp":1762421005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050118301359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":46,"alternative-id":["S2329050118301359"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2018.12.011","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2018.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s).","name":"copyright","label":"Copyright"}]}}